CXCL1 and colonic neoplasm: Subsequent research further revealed another mechanism by which mutant p53 proteins upregulate the expression of chemokines, showing that they can directly bind to and activate the CXCL1 or GRO1 promoters in SW480 colon cancer cells, thereby enhancing the oncogenic potential of mutant p53 [49].